6525--Nuclear Medicine NEURACEQ F-18 FLORBETABEN PET DEP
ID: 36C24925Q0157Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF249-NETWORK CONTRACT OFFICE 9 (36C249)MURFREESBORO, TN, 37129, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IMAGING EQUIPMENT AND SUPPLIES: MEDICAL, DENTAL, VETERINARY (6525)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/bf7bfe70920b4ef2b6fe5dcdfefaa0f0/view
Timeline
    Description

    The Department of Veterans Affairs is seeking small business vendors to provide F-18 Florbetaben PET doses for the Lexington VA Medical Center, as outlined in the combined synopsis and solicitation (RFQ 36C24925Q0157). The procurement involves a five-year contract for the delivery of specified quantities of radiopharmaceuticals, with orders required to be placed 24 hours prior to patient studies and delivered 15-30 minutes before calibration time. This initiative is crucial for ensuring timely access to essential medical imaging supplies, thereby enhancing the quality of healthcare services provided to veterans. Interested vendors must submit their quotes by March 6, 2025, and can direct inquiries to Contract Specialist Ayslin Kennett at Ayslin.Kennett@va.gov.

    Point(s) of Contact
    Ayslin KennettContract Specialist
    No phone calls will be accepted
    Ayslin.Kennett@va.gov
    Files
    Title
    Posted
    36C24925Q0157.pdf
    The Department of Veterans Affairs (VA) is issuing a combined synopsis and solicitation for the procurement of F-18 Florbetaben PET doses at the Lexington VA Medical Center. This Request for Quotation (RFQ), designated as 36C24925Q0157, targets small business vendors and requires quotes to be submitted by March 6, 2025. The procurement encompasses a series of quantities over a five-year period, with specified unit doses and delivery timelines beginning March 15, 2025, through March 14, 2030. Quoters must comply with various submission requirements, including providing product specifications and demonstrating that the offered products meet outlined salient characteristics. Evaluation criteria for quotes will focus on price, technical capability, and past performance, with the objective of awarding the contract to the most advantageous offer for the government. The solicitation emphasizes compliance with federal regulations, including those related to service-disabled veteran-owned small businesses. Additional documentation and clauses governing the procurement can be accessed via the provided resources. This procurement signifies the government's commitment to acquiring essential medical imaging supplies in an efficient and equitable manner.
    SOW-NEURACEQ.pdf
    The document outlines the Statement of Work for the delivery of Neuraceq-F18 fluorbetaben radiopharmaceuticals to the Nuclear Medicine/PET Department of the Lexington, KY VA Healthcare System. The agreement covers a base period of 12 months with an option for four additional years, emphasizing compliance with federal regulations concerning radiopharmaceutical delivery. Key requirements include timely orders placed 24 hours prior to patient studies, ensuring delivery 15-30 minutes before calibration time, and adherence to safety protocols, including proper packaging and documentation. The contractor must also handle invoicing and quality control, with strict guidelines regarding delivery errors and recalls. The contract will be awarded to the lowest price technically acceptable offeror, with past performance and response times also considered. This contract reflects the VA's commitment to providing quality healthcare services through timely and compliant radiopharmaceutical delivery.
    Lifecycle
    Title
    Type
    6525--Nuclear Medicine NEURACEQ F-18 FLORBETABEN PET DEP
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    6505--Lab supplies - Radiopharm - Amyvid
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for a five-year indefinite delivery indefinite quantity (IDIQ) contract to supply Amyvid injectables for Positron Emission Tomography (PET) imaging at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, Pennsylvania. The contract will require an estimated thirty-six doses of Amyvid per year, which are critical for diagnosing Alzheimer's disease in veterans. Proposals are due by 3:00 PM EST on March 6, 2025, with questions accepted until March 4, 2025, and the total contract value is capped at $1,000,000. Interested vendors must comply with federal regulations and safety guidelines, and they can contact Contracting Officer Victoria Droz at Victoria.Droz@va.gov or 814-515-4454 for further information.
    6505--Radiopharmaceuticals For The Portland VA Medical Center
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of radiopharmaceuticals for the Portland VA Medical Center. This opportunity, identified by solicitation number 36C26025Q0237, aims to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply essential nuclear medicine supplies, ensuring 24/7 availability and prompt delivery for patient care. The procurement is particularly significant as it supports the medical needs of veterans while promoting participation from Service-Disabled Veteran-Owned Small Businesses (SDVOSB). Interested vendors must submit their proposals by March 28, 2025, at 13:00 Pacific Time, and can direct inquiries to José Ronstadt at jose.ronstadt@va.gov or by phone at 360-852-9885.
    6505--Notice of Intent to Sole Source F18 Piflufolastat (PYLARIFY) Doses for PET/CT for Overton Brooks VA Medical Center, Shreveport, LA
    Buyer not available
    The Department of Veterans Affairs intends to award a sole-source contract to Progenics Pharmaceuticals, Inc. for the provision of 200 doses of F-18 Pifluflostat (PYLARIFY) for the Overton Brooks VA Medical Center in Shreveport, LA. The contractor must be licensed and experienced in supplying radiopharmaceuticals, ensuring compliance with regulatory standards set by the Nuclear Regulatory Commission and the FDA, and providing daily or as-needed deliveries to the facility's Nuclear Medicine department. This specialized radiopharmaceutical is crucial for PET imaging in prostate cancer patients, reflecting the government's commitment to high healthcare standards and patient safety. Interested vendors must submit their capability statements by March 3, 2025, and all inquiries should be directed to the contracting officer, Ross Futch, at ross.futch@va.gov or by phone at 713-770-2830.
    6505--Radiopharmaceutical Isotopes (Cardiology)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals from qualified small businesses for the provision of radiopharmaceutical isotopes specifically for use in nuclear cardiology procedures at the William S. Middleton Memorial Veterans Hospital in Madison, WI. The procurement aims to secure isotopes such as 99mTc-Tetrofosmin and 131I-Sodium Iodide, which are critical for diagnostic testing and quality assurance, with a contract period extending from April 1, 2025, to March 31, 2030, and options for renewal. Vendors must ensure compliance with safety regulations, quality control, and confidentiality in handling patient data, while providing robust ordering systems and next-day service capabilities. Interested parties should contact Contracting Officer Stacy Massey at Stacy.Massey@va.gov or 414-844-8400 for further details and to submit their quotes by the specified deadlines.
    6505--Bevacizumab Injection
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Bevacizumab injections, a critical pharmaceutical product used in various healthcare settings for veterans. Vendors are required to meet specific criteria, including providing unique National Drug Codes (NDC) and adhering to the Drug Supply Chain Security Act regulations, as the contract aims to ensure a reliable supply of this medication across government health care facilities. The selected contractor will be responsible for multiple line items of different Bevacizumab formulations, maintaining compliance with FDA manufacturing practices, and submitting quarterly sales reports, including cost recovery fees. Interested vendors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details, with submissions due by the specified deadlines outlined in the solicitation document.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6525--DEC 2024 Equipment Only Consolidation
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of medical equipment under the solicitation titled "6525--DEC 2024 Equipment Only Consolidation." This initiative aims to acquire high-tech medical imaging equipment, specifically targeting the needs of the National Acquisition Center (NAC) for various healthcare facilities serving veterans. The procurement process is crucial for enhancing healthcare services, ensuring that the VA can provide state-of-the-art diagnostic and treatment capabilities. Key deadlines include the submission of vendor questions by February 19, 2025, and the final offer submission due by April 9, 2025. Interested vendors should direct inquiries to Contract Specialist Hermann A. Degbegni at hermann.degbegni@va.gov for further details.
    Radiopharmaceuticals - Naval Medical Center Portsmouth
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting proposals for the provision of radiopharmaceuticals to the Naval Medical Center Portsmouth, with a contract period extending from April 1, 2025, to March 31, 2030. The procurement encompasses a range of medical isotopes and imaging agents, including Tc-99m Medronate, I-123 NaI, and F-18 FDG, which are critical for various diagnostic and therapeutic applications in cancer treatment and medical imaging. This initiative underscores the government's commitment to ensuring the availability of essential medical resources to support public health initiatives, with a focus on compliance with safety regulations and quality standards. Interested vendors must submit their proposals by March 11, 2025, and direct any inquiries to Carol Uebelacker at carol.e.uebelacker.civ@health.mil or by phone at 210-952-8111.
    6525--Automated Contrast Delivery System
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of an Automated Contrast Delivery System, specifically for the Phoenix VA Healthcare System. The system must effectively deliver contrast media and saline solutions during cardiac procedures, ensuring precise administration and the use of sterile, single-use components to maintain safety and prevent contamination. This procurement is vital for enhancing imaging capabilities in medical procedures and falls under NAICS Code 339112, focusing on surgical and medical instrument manufacturing. Interested vendors must submit their quotes by March 5, 2025, at 4:00 PM PST, and can contact Contract Specialist Nate Munson at nathan.munson@va.gov or 562-681-2951 for further information.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.